Le Lézard
Classified in: Health
Subject: TDS

2-Day Seminar: Process Validation Guidance Requirements - FDA and EU Annex 15 (Boston, MA, United States - May 10-11, 2018)


DUBLIN, April 12, 2018 /PRNewswire/ --

The "Process Validation Guidance Requirements (FDA and EU Annex 15: Qualifications and Validation): 2-Day Workshop " conference has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

This two day, interactive seminar which provides a conduit to enhance your understanding of the Continued Process Verification, will be reviewed in detail: where does it begin; what is included; and, when does it end.

These questions will be addressed within Stage 2 as presented here and include utilization of Process Validation and Phase 1, 2 and 3, where their Guidances blend and where they remain distinct. In particular, Stage 3.

Agenda

Day 01 (8:30 AM - 5:00 PM)

Day 02 (8:30 AM - 4:30 PM)

For more information about this conference visit https://www.researchandmarkets.com/research/65fs2x/2day_seminar?w=5


Media Contact:

Laura Wood, Senior Manager
[email protected]  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets


These press releases may also interest you

at 09:45
Proov, the creator of a suite of at-home fertility-related hormone tests, has announced today that an equity share of the company has been purchased by GRAMMY award-winning singer-songwriter, actor and author Ashanti and her fiancé, GRAMMY winning,...

at 09:38
The National Council on Aging (NCOA), the national voice for every person's right to age well, is hosting its 2024 Age+Action Conference on May 6-8, 2024, in Arlington, VA....

at 09:35
Prevent Blindness, the nation's leading nonprofit eye health and safety organization, has designated May as "Inherited Retinal Disease (IRD) Genetic Testing Awareness Month," expanding its previous IRD and Genetic Testing Awareness Week initiative....

at 09:30
Children's Minnesota and Minnesota Epilepsy Group are pleased to announce the re-accreditation of their epilepsy monitoring unit as a Level 4 Epilepsy Center. This accreditation is the highest of its kind by the National Association of Epilepsy...

at 09:30
Co-Diagnostics, Inc.  (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that the Company will be hosting a booth and delivering a...

at 09:30
Alaffia Health, the leader in generative AI for health plan claim operations, today announced $10M in Series A funding, bringing its total amount of capital raised to $17.6M. The round was led by FirstMark Capital, with participation from GingerBread...



News published on and distributed by: